Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001: Overview of activities by the Nordic Council on Medicines

Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages)

Índice de contenido

	Executive Summary
	Overview of activities by the World Health Organization - Dr Lembit Rägo
	Overview of activities by the Nordic Council on Medicines - Dr Ola Westbye
	Country Experiences
		Sweden: Publication bias of clinical trials - Dr Juliette Säwe
		The Netherlands: Pharmaceuticals and e-commerce - Dr Hans Heuvelmans
		Denmark: Web site of the Institute for Rational Pharmacotherapy - Ms Karin Friis Bach
		Denmark: Danish Medicines Agency web site - Mr Karsten Jørgensen
		South Africa: The South African perspective on medicine regulation - Dr Wilbert Bannenberg
		Tunisia - Dr Amor Toumi
		Estonia - Dr Main Uusküla
		Bulgaria: Bulgarian Drug Agency - Rozalina Asenova Kulaksazova
	The Danish Consumer Council - Ms Margrethe Nielsen
	Swedish Industry Association - Dr Håkan Mandahl
	Introduction to discussion points - Dr Lembit Rägo
	Quality aspects - Dr Ola Westbye
	Pilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
	The WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
	Concluding discussion
	Annexes
		Annex 1. List of Participants
		Annex 2. List of DRA web sites
	References
	Back cover

Overview of activities by the Nordic Council on Medicines - Dr Ola Westbye

Dr Ola Westbye
Nordic Council on Medicines, Norway

Much has been done by the Nordic Council on Medicines (NLN) in the area of pharmaceuticals. They have worked on the quality of the information about medicinal products that are available on the Internet. A proposed quality symbol for web sites that meet specific criteria (the ‘Nordic Symbol for Reliable Information on Medicines’) has been produced. Seminars and conferences have also been organized by NLN on e-medicines, medicines on the Internet, harmonization of the Nordic drug regulatory authorities’ administrative practices, etc.